The British scientist and entrepreneur aims to take a more active role in influencing Abcam’s governance, performance and direction, according to a
He’s already held several discussions with the company and has been seeking a board seat, according to a person familiar with the matter, who asked not to be identified because the information is private.
Milner is one of Cambridge, England-based Abcam’s largest investors with a stake of about 6.4%, ...
Learn more about Bloomberg Law or Log In to keep reading:
See Breaking News in Context
Bloomberg Law provides trusted coverage of current events enhanced with legal analysis.
Already a subscriber?
Log in to keep reading or access research tools and resources.